Reverse-phase protein arrays for application-orientated cancer research
A detailed and quantitative analysis of disease‐relevant signaling will greatly contribute to our understanding of tumorigenesis and cancer progression, and thus open new strategies for drug discovery. However, throughput and sensitivity of currently established methods available for proteome profil...
Saved in:
Published in | Proteomics. Clinical applications Vol. 3; no. 10; pp. 1140 - 1150 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
01.10.2009
WILEY‐VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A detailed and quantitative analysis of disease‐relevant signaling will greatly contribute to our understanding of tumorigenesis and cancer progression, and thus open new strategies for drug discovery. However, throughput and sensitivity of currently established methods available for proteome profiling do not comply with the needs of clinical research such as high sample capacity and low sample consumption. Protein microarrays emerged as a promising alternative to analyze the abundance of proteins and their phosphorylation status on a high‐throughput level. Here we summarize recent methodological advancements in the field of reverse‐phase protein arrays and demonstrate their potential for clinical research as well as for in vitro applications. |
---|---|
Bibliography: | ark:/67375/WNG-8L7K7403-S German Federal Ministry for Education and Research (BMBF) - No. PTJ-Bio/0313336; No. 01GR0418 National Genome Research Net (NGFN) ArticleID:PRCA200780035 istex:ABDB82592B773218DBEA69CEEE000C60B64657CD ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1862-8346 1862-8354 |
DOI: | 10.1002/prca.200780035 |